IR-Med Inc. logo

IR-Med Inc. (IRME)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
162.2K Market Cap
- P/E Ratio
- Div Yield
594 Volume
-0.07 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0.05
Want to track IRME and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

IRME closed Monday higher at $0, an increase of 0% from Friday's close, completing a monthly decrease of -70% or $0. Over the past 12 months, IRME stock lost -94.7368%.
IRME is not paying dividends to its shareholders.
The last earnings report, released on Jun 03, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
IR-Med Inc. has completed 1 stock splits, with the recent split occurring on Feb 26, 2020.
The company's stock is traded on one exchange.

IRME Chart

People also search for

Decker Manufacturing Corporation
$ 57.01
0%
Cannabix Technologies Inc.
$ 0.38
-1.8088%
VicapSys Life Sciences Inc.
$ 1.45
0%
Nuo Therapeutics Inc.
$ 0.85
0%
Quantumzyme Corp.
$ 0.8
+33.3333%

IR-Med Inc. (IRME) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

IR-Med Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is IRME.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 162.2K.

Has IR-Med Inc. ever had a stock split?

IR-Med Inc. had 1 splits and the recent split was on Feb 26, 2020.

IR-Med Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Oded Bashan CEO
OTC PINK Exchange
46265R103 CUSIP
IL Country
3 Employees
- Last Dividend
26 Feb 2020 Last Split
- IPO Date

Overview

IR-Med Inc. operates as a development stage medical device company, with a primary focus on creating non-invasive devices tailored for various medical needs. Situated in Rosh Pina, Israel, the company commits itself to innovation in the medical field, aiming to enhance patient care and diagnostic procedures using cutting-edge technology. Their mission is evident in the development of devices like PressureSafe and Nobiotics, which represent significant advancements in medical diagnostics and patient care, especially in areas that have traditionally relied on invasive methods or extensive wait times for results.

Products and Services

  • PressureSafe:
  • A revolutionary handheld optical monitoring device from IR-Med Inc., PressureSafe is designed to aid in the early detection of pressure injuries to the skin and underlying tissue. These injuries are primarily caused by prolonged pressure, often associated with bed confinement, making this device particularly useful in clinical settings where patients are at risk of developing such conditions. Its non-invasive nature not only allows for quicker assessments but also significantly reduces the discomfort associated with traditional methods of detection.

  • Nobiotics:
  • The Nobiotics otoscope is another innovative device by IR-Med Inc., engineered to assist physicians by providing immediate indications of mid-ear infections, a common ailment particularly in children. This tool simplifies and speeds up the diagnosis process, potentially improving outcomes by facilitating quicker treatment strategies. Its design and functionality highlight IR-Med Inc.'s dedication to enhancing diagnostic procedures, reducing the strain on both medical professionals and patients, and paving the way for more efficient and effective healthcare solutions.

Contact Information

Address: ZHR Industrial Zone
Phone: 972 4 655 5054